AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
58-country EV dashboard shows Europe at 23.6% fully electric share
AGP
Automotive Cloud’s 2026 dashboard tracks vehicle sales across 58 countries and shows how uneven the EV transition remains across major markets.
Practical DevSecOps pitches security champion training for EU CRA deadline
AGP
Practical DevSecOps is promoting its Certified Security Champion program as companies race toward the EU Cyber Resilience Act’s final compliance deadline in December 2027. The move comes as the law already requires 24-hour vulnerability reporting…
Beovu market seen growing on retinal disease demand and aging populations
AGP
The Business Research Company says the global Beovu market is expanding as retinal disease rates rise, older populations grow and healthcare spending increases.
BayTet market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the BayTet market is set to expand through 2035, driven by rising tetanus cases, more surgeries and broader immunization gaps.
FusionAuth opens UK sales team as Europe demand rises
AGP
FusionAuth says European demand for data sovereignty and tenant isolation is driving rapid growth, prompting the identity platform to set up its first dedicated sales team in the UK. The company also reported 48% year-over-year growth in…
Besremi market seen growing on rising MPN diagnoses and longer-acting treatments
AGP
The Business Research Company says the Besremi market is poised for steady expansion through 2035, driven by rising diagnoses of myeloproliferative neoplasms, growing use of longer-acting interferons, and broader access to specialty hematology…
Bayhep B market set for growth on hepatitis B demand and aging population
AGP
The Business Research Company says the Bayhep B market will keep expanding through 2026, driven by higher hepatitis B prevalence, more liver transplant activity, and broader use of post-exposure prophylaxis.
Berinert market seen expanding through 2030 on better diagnosis and access
AGP
The Business Research Company says the Berinert market is set for continued growth through 2030 as hereditary angioedema diagnosis improves, healthcare spending rises and more patients gain access to plasma-derived treatments.
Bayrab market seen expanding as rabies prevention demand rises
AGP
The Business Research Company says the global Bayrab vaccine market is set for notable growth through 2035, driven by more rabies cases, higher healthcare spending and wider use of pre- and post-exposure prophylaxis.
Konecta named a Major Contender in Everest Group’s 2026 Europe DWS report
AGP
Konecta was recognized by Everest Group as a Major Contender in its Digital Workplace Services PEAK Matrix assessment for Europe, marking the company’s first inclusion in the ranking.
Columvi market forecast points to strong growth through 2035
AGP
The Business Research Company says the global Columvi market is set to expand through 2035, driven by rising relapsed lymphoma cases, aging populations and wider use of targeted immunotherapies.
Cinqair market report points to growth in severe asthma biologics through 2035
AGP
The Business Research Company says the Cinqair, also called Cinqaero, market is set to expand through 2035 as severe eosinophilic asthma treatments shift toward biologics and more targeted care.
Cuvitru market seen growing through 2030 on immunodeficiency demand
AGP
The Business Research Company says the global Cuvitru market is gaining momentum through 2030 as more patients are diagnosed with immunodeficiency disorders and demand rises for home-based immunoglobulin therapy.
Curosurf market report points to steady growth in neonatal care demand
AGP
The Business Research Company says the Curosurf (poractant alfa) market is set for steady expansion as premature births rise and neonatal intensive care use grows.
Corifact market outlook improves on rising global demand
AGP
The Business Research Company says the global Corifact market is poised for faster growth through 2035, driven by more bleeding disorders, more surgeries and broader use of fibrinogen concentrates.
Comirnaty market forecast to double by 2030 as booster demand stays strong
AGP
The Business Research Company says the global Comirnaty (tozinameran) market will grow from $8.26 million in 2025 to $21.81 million by 2030, fueled by booster demand, mRNA adoption and pandemic preparedness spending.
Cyfendus market set for faster growth as anthrax preparedness spending rises
AGP
The global Cyfendus vaccine market is gaining momentum as governments step up biodefense planning and anthrax preparedness.
Cotazym market seen growing through 2030 on digestive care demand
AGP
The Business Research Company says the Cotazym market is being lifted by rising gastrointestinal disease, more diagnoses of pancreatic insufficiency and broader use of enzyme replacement therapy.
Chorionic gonadotropin market seen reaching $1.82 million by 2030
AGP
The Business Research Company says the chorionic gonadotropin market will grow from $1.34 million in 2025 to $1.43 million in 2026, then reach $1.82 million by 2030. The report points to rising infertility, broader use of assisted reproductive…
CNJ-016 market forecast points to steady growth through 2035
AGP
The Business Research Company projects the CNJ-016 market will expand through 2035, driven by rising immunodeficiency cases, smallpox vaccine use, and growing interest in personalized medicine.
Sign up for:
European Global Times
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.